Acorah Software Products - Accounts Production 16.1.300 false true 31 December 2022 1 January 2022 false 1 January 2023 31 December 2023 31 December 2023 12997701 Dr Bhavesh Sachdev iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12997701 2022-12-31 12997701 2023-12-31 12997701 2023-01-01 2023-12-31 12997701 frs-core:CurrentFinancialInstruments 2023-12-31 12997701 frs-core:ComputerEquipment 2023-12-31 12997701 frs-core:ComputerEquipment 2023-01-01 2023-12-31 12997701 frs-core:ComputerEquipment 2022-12-31 12997701 frs-core:ShareCapital 2023-12-31 12997701 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 12997701 frs-bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 12997701 frs-bus:FilletedAccounts 2023-01-01 2023-12-31 12997701 frs-bus:SmallEntities 2023-01-01 2023-12-31 12997701 frs-bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 12997701 frs-bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 12997701 frs-core:ListedExchangeTraded 2023-12-31 12997701 frs-core:ListedExchangeTraded 2022-12-31 12997701 frs-core:CostValuation frs-core:ListedExchangeTraded 2022-12-31 12997701 frs-core:AdditionsToInvestments frs-core:ListedExchangeTraded 2023-12-31 12997701 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:ListedExchangeTraded 2023-12-31 12997701 frs-core:CostValuation frs-core:ListedExchangeTraded 2023-12-31 12997701 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2022-12-31 12997701 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2023-12-31 12997701 frs-bus:Director1 2023-01-01 2023-12-31 12997701 frs-bus:Director1 2022-12-31 12997701 frs-bus:Director1 2023-12-31 12997701 frs-countries:EnglandWales 2023-01-01 2023-12-31 12997701 2021-12-31 12997701 2022-12-31 12997701 2022-01-01 2022-12-31 12997701 frs-core:CurrentFinancialInstruments 2022-12-31 12997701 frs-core:ShareCapital 2022-12-31 12997701 frs-core:RetainedEarningsAccumulatedLosses 2022-12-31
Registered number: 12997701
Heart Doctor Limited
Unaudited Financial Statements
For The Year Ended 31 December 2023
Sharpe Medical Accounting Ltd
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 12997701
2023 2022
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 665 -
Investments 5 99,385 54,000
100,050 54,000
CURRENT ASSETS
Debtors 6 15,645 7,543
Cash at bank and in hand 52,885 54,877
68,530 62,420
Creditors: Amounts Falling Due Within One Year 7 (25,372 ) (22,126 )
NET CURRENT ASSETS (LIABILITIES) 43,158 40,294
TOTAL ASSETS LESS CURRENT LIABILITIES 143,208 94,294
NET ASSETS 143,208 94,294
CAPITAL AND RESERVES
Called up share capital 8 100 100
Profit and Loss Account 143,108 94,194
SHAREHOLDERS' FUNDS 143,208 94,294
Page 1
Page 2
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Bhavesh Sachdev
Director
25/10/2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Heart Doctor Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12997701 . The registered office is C/O Sharpe Medical Accounting Ltd, Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is recognised when a company gains entitlement to receive income from a third party.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25% Straight Line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2022: 1)
1 1
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 January 2023 -
Additions 679
As at 31 December 2023 679
Depreciation
As at 1 January 2023 -
Provided during the period 14
As at 31 December 2023 14
Net Book Value
As at 31 December 2023 665
As at 1 January 2023 -
5. Investments
Listed
£
Cost
As at 1 January 2023 54,000
Additions 40,000
Revaluations 5,385
As at 31 December 2023 99,385
Provision
As at 1 January 2023 -
As at 31 December 2023 -
Net Book Value
As at 31 December 2023 99,385
As at 1 January 2023 54,000
Page 4
Page 5
6. Debtors
2023 2022
£ £
Due within one year
Trade debtors 8,303 1,400
Other debtors 7,342 6,143
15,645 7,543
7. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Other creditors 1,797 1,696
Taxation and social security 23,575 20,430
25,372 22,126
8. Share Capital
2023 2022
£ £
Allotted, Called up and fully paid 100 100
9. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 January 2023 Amounts advanced Amounts repaid Amounts written off As at 31 December 2023
£ £ £ £ £
Dr Bhavesh Sachdev 6,143 1,434 312 - 7,265
The above loan is unsecured, interest free and repayable on demand.
Page 5